Aktie A110020 JEONJINBIO CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jeonjinbio Co., Ltd.

Aktien

A110020

KR7110020005

A110020

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
3’830 KRW +1.46% Intraday Chart für Jeonjinbio Co., Ltd. -8.92% -52.30%
13.06. Dabin BNS Co., Ltd. hat die Übernahme von 7,42% der Anteile an Jeonjinbio Co., Ltd. (KOSDAQ:A110020) von Lee Tae Hoon und Woo Sang Hyun. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Dabin BNS Co., Ltd. cancelled the acquisition of 7.42% stake in Jeonjinbio Co., Ltd. from Lee Tae Hoon and Woo Sang Hyun.
Jeonjinbio Co., Ltd. announced that it has received KRW 20 billion in funding
Dabin BNS Co., Ltd. agreed to acquire 7.42% stake in Jeonjinbio Co., Ltd. from Lee, Tae Hoon and Woo Sang Hyun for KRW 22 billion.
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 7.99999617 billion in funding
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 20 billion in funding
Jeonjinbio Co., Ltd. announced that it has received KRW 1.797564755 billion in funding
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 1.797564755 billion in funding
Jeonjinbio Co., Ltd. announced that it has received KRW 5 billion in funding
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 5 billion in funding
Jeonjinbio Co., Ltd. announced that it has received KRW 6.3 billion in funding from Korea Investment & Securities Co., Ltd., Shinhan Financial Investment Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, and other investors
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 6.3 billion in funding from Korea Investment & Securities Co., Ltd., Shinhan Financial Investment Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, and other investors
Jeonjinbio Co., Ltd. announced that it has received KRW 3.5 billion in funding from KB Securities Co., Ltd., Investment Arm
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding from KB Securities Co., Ltd., Investment Arm and other investors
Jeonjinbio Co., Ltd. announced that it has received KRW 2.2 billion in funding
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 2.2 billion in funding
Jeonjinbio Co., Ltd. has completed an IPO in the amount of KRW 5 billion.
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 1.718 billion in funding
Jeonjinbio Co., Ltd. announced that it has received KRW 990 million in funding
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 990 million in funding
Jeonjinbio Co., Ltd. announced that it has received KRW 500 million in funding from Findvalue Asset Management Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A110020 Aktie
  4. Nachrichten Jeonjinbio Co., Ltd.
  5. Andere Sprachen